Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Toronto

$25,000.00

Characterization of the structure and stability of human serum albumin isolated using a novel plasma extraction technique****

FY 2018-19

Summary
Molecular chaperones are a highly interactive group of cellular proteins that fulfill central roles in all aspects of protein homeostasis including protein folding, assembly, and unfolding of substrates. Chaperones are typically categorized into families based on their sequence similarity and function. Another characteristic feature of molecular chaperones is their ability to suppress protein aggregation under stress conditions. In this regard, human serum albumin (HSA) acts like a chaperone protein preventing protein aggregation. HSA is one of the most abundant proteins in blood plasma. It is essential for the transport of free fatty acids, ions, bile salts and other compounds. It is also required to maintain the colloidal osmotic pressure in the body and provides the majority of plasma anti-oxidant activity. Importantly, the depletion of HSA from human plasma results in a large increase in protein aggregation under physiological stress conditions. *In this Engage project, the Houry group will collaborate with Evolve Biologics to characterize the structure and function of HSA generated by the company's unique proprietary technology, termed 'PlasmaCap EBATM', to extract proteins from blood plasma. This novel technique has resulted in the extraction of more proteins at higher purity from each liter of donor plasma as compared to the legacy technology in the plasma products industry. The project represents a natural collaboration for the two groups, since the Houry group studies molecular chaperones using the latest biochemical, biophysical, and structural approaches, while Evolve Biologics has extensive experience in plasma proteins. *One of Evolve Biologics' priorities is in developing and commercializing well-established plasma protein therapeutics, such as HSA. Hence, this collaboration will have direct translational benefits in improving people's health in Canada and worldwide dependent on plasma protein therapeutics.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
533721-2018
Name nom
Houry, Walid
Department département
Biochemistry (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Partie
1
Nb partie
1
Application title
Characterization of the structure and stability of human serum albumin isolated using a novel plasma extraction technique****
Keyword
NSERC
Application summary
Molecular chaperones are a highly interactive group of cellular proteins that fulfill central roles in all aspects of protein homeostasis including protein folding, assembly, and unfolding of substrates. Chaperones are typically categorized into families based on their sequence similarity and function. Another characteristic feature of molecular chaperones is their ability to suppress protein aggregation under stress conditions. In this regard, human serum albumin (HSA) acts like a chaperone protein preventing protein aggregation. HSA is one of the most abundant proteins in blood plasma. It is essential for the transport of free fatty acids, ions, bile salts and other compounds. It is also required to maintain the colloidal osmotic pressure in the body and provides the majority of plasma anti-oxidant activity. Importantly, the depletion of HSA from human plasma results in a large increase in protein aggregation under physiological stress conditions. *In this Engage project, the Houry group will collaborate with Evolve Biologics to characterize the structure and function of HSA generated by the company's unique proprietary technology, termed 'PlasmaCap EBATM', to extract proteins from blood plasma. This novel technique has resulted in the extraction of more proteins at higher purity from each liter of donor plasma as compared to the legacy technology in the plasma products industry. The project represents a natural collaboration for the two groups, since the Houry group studies molecular chaperones using the latest biochemical, biophysical, and structural approaches, while Evolve Biologics has extensive experience in plasma proteins. *One of Evolve Biologics' priorities is in developing and commercializing well-established plasma protein therapeutics, such as HSA. Hence, this collaboration will have direct translational benefits in improving people's health in Canada and worldwide dependent on plasma protein therapeutics.